Literature DB >> 32691348

Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation.

John D Groarke1, Sanjay Divakaran1,2, Anju Nohria1, Joseph H Killoran3, Sharmila Dorbala2, Ruth M Dunne2, Jon Hainer2, Viviany R Taqueti2, Ron Blankstein1,2, Harvey J Mamon3, Marcelo F Di Carli4,5.   

Abstract

BACKGROUND: We sought to test the hypothesis that thoracic radiation therapy (RT) is associated with impaired myocardial flow reserve (MFR), a measure of coronary vasomotor dysfunction.
METHODS: We retrospectively studied thirty-five consecutive patients (71% female, mean ± standard deviation (SD) age: 66 ± 11 years) referred clinically for positron emission tomography/computed tomography (PET/CT) myocardial perfusion imaging at a median (interquartile range, IQR) interval of 4.3 (2.1, 9.7) years following RT for a variety of malignancies. Radiation dose-volume histograms were generated for the heart and coronary arteries for each patient.
RESULTS: The median (IQR) of mean cardiac radiation doses was 12.0 (1.2, 24.2) Gray. There were significant inverse correlations between mean radiation dose and global MFR (MFRGlobal) and MFR in the left anterior descending artery territory (MFRLAD): Pearson's correlation coefficient = - .37 (P = .03) and - .38 (P = .03), respectively. For every one Gray increase in mean cardiac radiation dose, there was a mean ± standard error decrease of .02 ± .01 in MFRGlobal (P = .04) and MFRLAD (P = .03) after adjustment.
CONCLUSIONS: In patients with a history of RT clinically referred for cardiac stress PET, we found an inverse correlation between mean cardiac radiation dose and coronary vasomotor function.
© 2020. American Society of Nuclear Cardiology.

Entities:  

Keywords:  MPI; Microvascular dysfunction; PET; atherosclerosis; myocardial blood flow

Mesh:

Year:  2020        PMID: 32691348      PMCID: PMC7855471          DOI: 10.1007/s12350-020-02255-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  40 in total

1.  Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.

Authors:  Patrizio Lancellotti; Vuyisile T Nkomo; Luigi P Badano; Jutta Bergler-Klein; Jan Bogaert; Laurent Davin; Bernard Cosyns; Philippe Coucke; Raluca Dulgheru; Thor Edvardsen; Oliver Gaemperli; Maurizio Galderisi; Brian Griffin; Paul A Heidenreich; Koen Nieman; Juan C Plana; Steven C Port; Marielle Scherrer-Crosbie; Ronald G Schwartz; Igal A Sebag; Jens-Uwe Voigt; Samuel Wann; Phillip C Yang
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-08       Impact factor: 6.875

Review 2.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

Authors:  M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

3.  Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer.

Authors:  Christina K Speirs; Todd A DeWees; Sana Rehman; Alerson Molotievschi; Maria A Velez; Daniel Mullen; Sandra Fergus; Marco Trovo; Jeffrey D Bradley; Cliff G Robinson
Journal:  J Thorac Oncol       Date:  2016-10-12       Impact factor: 15.609

4.  Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.

Authors:  Katelyn M Atkins; Bhupendra Rawal; Tafadzwa L Chaunzwa; Nayan Lamba; Danielle S Bitterman; Christopher L Williams; David E Kozono; Elizabeth H Baldini; Aileen B Chen; Paul L Nguyen; Anthony V D'Amico; Anju Nohria; Udo Hoffmann; Hugo J W L Aerts; Raymond H Mak
Journal:  J Am Coll Cardiol       Date:  2019-06-18       Impact factor: 24.094

Review 5.  Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients.

Authors:  F A Stewart; S Hoving; N S Russell
Journal:  Radiat Res       Date:  2010-08-30       Impact factor: 2.841

6.  Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation.

Authors:  Shira L Galper; James B Yu; Peter M Mauch; Jon F Strasser; Barbara Silver; Ann Lacasce; Karen J Marcus; Mary Ann Stevenson; Ming Hui Chen; Andrea K Ng
Journal:  Blood       Date:  2010-09-21       Impact factor: 22.113

7.  Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Robert T Dess; Yilun Sun; Martha M Matuszak; Grace Sun; Payal D Soni; Latifa Bazzi; Venkatesh L Murthy; Jason W D Hearn; Feng-Ming Kong; Gregory P Kalemkerian; James A Hayman; Randall K Ten Haken; Theodore S Lawrence; Matthew J Schipper; Shruti Jolly
Journal:  J Clin Oncol       Date:  2017-03-16       Impact factor: 44.544

8.  Risk of ischemic heart disease in women after radiotherapy for breast cancer.

Authors:  Sarah C Darby; Marianne Ewertz; Paul McGale; Anna M Bennet; Ulla Blom-Goldman; Dorthe Brønnum; Candace Correa; David Cutter; Giovanna Gagliardi; Bruna Gigante; Maj-Britt Jensen; Andrew Nisbet; Richard Peto; Kazem Rahimi; Carolyn Taylor; Per Hall
Journal:  N Engl J Med       Date:  2013-03-14       Impact factor: 91.245

9.  Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977-2005.

Authors:  Jens Christian Rehammar; Maj-Britt Jensen; Paul McGale; Ebbe Laugaard Lorenzen; Carolyn Taylor; Sarah C Darby; Lars Videbæk; Zhe Wang; Marianne Ewertz
Journal:  Radiother Oncol       Date:  2017-03-30       Impact factor: 6.280

10.  Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The Teenage and Young Adult Cancer Survivor Study.

Authors:  Katherine E Henson; Raoul C Reulen; David L Winter; Chloe J Bright; Miranda M Fidler; Clare Frobisher; Joyeeta Guha; Kwok F Wong; Julie Kelly; Angela B Edgar; Martin G McCabe; Jeremy Whelan; David J Cutter; Sarah C Darby; Mike M Hawkins
Journal:  Circulation       Date:  2016-11-07       Impact factor: 29.690

View more
  2 in total

1.  Call on the reserve: Coronary vasomotor dysfunction is a potential biomarker of cardiovascular risk in patients with breast cancer.

Authors:  Michael T Osborne; Simran Grewal; Tomas G Neilan
Journal:  J Nucl Cardiol       Date:  2021-12-14       Impact factor: 3.872

2.  Coronary vasomotor dysfunction portends worse outcomes in patients with breast cancer.

Authors:  Sanjay Divakaran; Jesse P Caron; Wunan Zhou; Jon Hainer; Courtney F Bibbo; Hicham Skali; Viviany R Taqueti; Sharmila Dorbala; Ron Blankstein; John D Groarke; Anju Nohria; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2021-11-24       Impact factor: 3.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.